| |
| |
|
| Insider
Information: |
Steiner Mitchell Shuster |
| Relationship: |
President and CEO, Dir... |
| City: |
Memphis |
| State: |
TN |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
9,142,814 |
|
|
Indirect Shares
|
2,687,445 |
|
|
| Direct
Value |
$9,986,729 |
|
|
|
Indirect Value
|
$1,061,464 |
|
|
| Total
Shares |
11,830,259 |
|
|
| Total
Value |
$11,048,193 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -65.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Oncternal Therapeutics Inc |
ONCT |
Chief Executive Office... |
2012-07-16 |
2,129,922 |
2012-07-16 |
2,543,445 |
Premium* |
|
|
Veru Inc |
VERU |
President and CEO, Dir... |
2024-05-17 |
7,012,892 |
2024-05-17 |
144,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
145 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ONCT |
Oncternal Therapeutics In... |
Chief Executive OfficerOfficer |
• • • |
2004-02-02 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
5,662,147 |
|
- |
|
| VERU |
Veru Inc |
President and CEOOfficer |
• • • |
2016-10-31 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
633,589 |
|
- |
|
| VERU |
Veru Inc |
President and CEOOfficer |
• • • |
2016-10-31 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
645,502 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2005-08-01 |
4 |
A |
$0.00 |
$0 |
D/D |
26,500 |
26,500 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2005-08-01 |
4 |
A |
$0.00 |
$0 |
I/I |
26,500 |
26,500 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2005-08-01 |
4 |
D |
$0.00 |
$0 |
I/I |
(53,000) |
4,917,206 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
officerTitle |
• • • |
2005-12-06 |
4 |
S |
$7.44 |
$372,000 |
D/D |
(50,000) |
26,500 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
officerTitle |
• • • |
2005-12-06 |
4 |
S |
$7.44 |
$372,000 |
I/I |
(50,000) |
26,500 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2006-02-24 |
4 |
AS |
$0.00 |
$0 |
I/I |
(500,000) |
4,409,862 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2006-02-24 |
4 |
A |
$0.00 |
$0 |
I/I |
500,000 |
500,000 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2006-03-09 |
4 |
AS |
$11.16 |
$40,257 |
I/I |
(3,538) |
493,000 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2006-03-09 |
4 |
AS |
$11.14 |
$39,334 |
I/I |
(3,462) |
496,538 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2006-03-10 |
4 |
AS |
$11.11 |
$3,335 |
I/I |
(300) |
492,700 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2006-03-10 |
4 |
AS |
$11.15 |
$62,423 |
I/I |
(5,550) |
487,150 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2006-03-10 |
4 |
AS |
$11.18 |
$12,932 |
I/I |
(1,150) |
486,000 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2006-03-16 |
4 |
AS |
$11.36 |
$63,862 |
I/I |
(5,499) |
480,501 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2006-03-16 |
4 |
AS |
$11.39 |
$20,611 |
I/I |
(1,776) |
477,443 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2006-03-17 |
4 |
AS |
$11.61 |
$24,436 |
I/I |
(2,082) |
476,643 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2006-03-17 |
4 |
AS |
$11.59 |
$54,189 |
I/I |
(4,643) |
472,000 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2006-03-23 |
4 |
AS |
$10.87 |
$64,677 |
I/I |
(5,895) |
465,779 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2006-03-23 |
4 |
AS |
$10.88 |
$8,547 |
I/I |
(779) |
465,000 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2006-03-24 |
4 |
AS |
$10.57 |
$62,878 |
I/I |
(5,862) |
459,138 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2006-03-24 |
4 |
AS |
$10.56 |
$12,126 |
I/I |
(1,138) |
458,000 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2006-03-26 |
4 |
AS |
$11.07 |
$3,609 |
I/I |
(326) |
468,980 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2006-03-30 |
4 |
AS |
$10.55 |
$25,604 |
I/I |
(2,414) |
444,000 |
|
- |
|
145 Records found
|
|
Page 1 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
